Careers  |  Sign In  |  Register

Recent Cancer Research May Hold Key to Treatment for SARS-CoV-2

Paula J. Bates, PhD, professor of medicine at the University of Louisville School of Medicine, and colleagues John O. Trent, PhD, and Donald M. Miller, MD, PhD, have been developing a cancer therapy based on their discovery of a synthetic piece of DNA known as an aptamer. This aptamer has properties that cause it to bind to a human protein called nucleolin, which early tests show might be an ideal way of starving a virus of a major fuel source for replication in the human body. The research team has applied for fast-track status from the US FDA for the potential COVID-19 treatment.

Read more about this research in UofL News by clicking here.